Image by Pete Linforth from Pixabay
Share, email, print, bookmark SOURCE reports.

[broadstreet zone=”53130″]

WASHINGTON DC – The Centers for Disease Control and Prevention and the Food and Drug Administration in a joint statement today, April 13, said the two federal agencies are investigating clots in six women that occurred 6 to 13 days after vaccination, and are recommending pausing the Johnson & Johnson one-shot COVID-19 vaccine.

The clots were observed in the sinuses of the brain along with reduced platelet counts — making the usual treatment for blood clots, the blood thinner heparin, potentially “dangerous.”

[broadstreet zone=”58892″]

Due to the investigation, there is a recommendation to “pause” the administration of the single-dose Johnson & Johnson COVID-19 vaccine.

Massachusetts’ Department of Public Health announced this morning, April 13, it is pausing administration of the Johnson & Johnson COVID-19 vaccine following the federal recommendation.

In 2021, more than 6.8 million doses of the J&J vaccine have been administered in the U.S.

Most individuals have experience none or mild side effects with the vaccine.

There are two other COVID-19 vaccines available Moderna and Pfizer, but both require two shots.

[broadstreet zone=”59946″]

By editor

Susan Petroni is the former editor for SOURCE. She is the founder of the former news site, which as of May 1, 2023, is now a self-publishing community bulletin board. The website no longer has a journalist but a webmaster.